Randomized trials are frequently fragmented in multiple secondary publications

References

Page 1

	Year	Citations
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars Wallentin, Richard C. Becker, Andrzej Budaj, New England Journal of Medicine	2009	7K
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis Steven R. Cummings, Javier San Martín, Michael R. McClung, New England Journal of Medicine	2009	3.4K
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events Arthur J. Moss, William J. Hall, David S. Cannom, New England Journal of Medicine	2009	3.1K
Mortality Results from a Randomized Prostate-Cancer Screening Trial Gerald L. Andriole, E. David Crawford, Robert L. Grubb, New England Journal of Medicine	2009	2.9K
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure Christopher M. O’Connor, David J. Whellan, Kerry L. Lee, JAMA	2009	2.1K
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials An‐Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr, JAMA	2004	1.8K
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Philip Home, Stuart Pocock, Henning Beck‐Nielsen, The Lancet Open-label TrialDiabetes ManagementCardiovascular DiseaseCardiovascular OutcomesMedicine	2009	1.4K
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials Rui Wang, Stephen W. Lagakos, James H. Ware, New England Journal of Medicine EngineeringGenetic EpidemiologyProspective Cohort StudyClinical TrialsBiostatistics	2007	1.4K
A method for assessing the quality of a randomized control trial Thomas C. Chalmers, Harry Smith, Bradley A. Blackburn, Controlled Clinical Trials ReliabilityEngineeringClinical Trial ManagementStatisticsClinical Trials	1981	1.4K
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Peter M. Rothwell The Lancet Retrospective Cohort StudyMeta-analysisHealth PolicyClinical Trial AnalysisClinical Trials	2005	914

Page 1